Clinical trial

A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis…

NCT00304291 · State University of New York at Buffalo, Other · Completed

Key facts

NCT number NCT00304291
Title A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
Official title A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
Lead sponsor State University of New York at Buffalo, Other
Collaborators EMD Serono Industry
Status Completed
Phase Phase 4
Study type Interventional
Conditions Neuromyelitis Optica, Myelitis, Transverse, Demyelinating Autoimmune Diseases, CNS, Autoimmune Diseases of the Nervous System
Intervention type Drug
Interventions Mitoxantrone
Enrollment 5
Start date Aug 1, 2001
Completion May 1, 2004
First posted Mar 17, 2006
Last update posted Dec 28, 2020
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies